Joseph Mazar

3PUBLICATIONS
8CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jan 12, 2024
The Oncolytic Activity of Zika Viral Therapy in Human Neuroblastoma In Vivo Models Confers a Major Survival Advantage in a CD24-dependent Manner.

Joseph Mazar, Jeanne K Brooks, Matthew Peloquin

|Jul 26, 2018
Zika virus as an oncolytic treatment of human neuroblastoma cells requires CD24.

Joseph Mazar, Yujia Li, Amy Rosado

|Jul 14, 2017
Nanoparticle delivery of curcumin induces cellular hypoxia and ROS-mediated apoptosis via modulation of Bcl-2/Bax in human neuroblastoma.

Irina Kalashnikova, Joseph Mazar, Craig J Neal

Pageof 1

Frequent Collaborators

1 joint publications

Sudipta Seal

1 joint publications

Jeanne K Brooks

1 joint publications

Matthew Peloquin

1 joint publications

Rosa Rosario